The NHS should not deny treatment to patients who pay privately for unapproved drugs, King's Fund chief executive Niall Dickson has said.
He told a seminar yesterday: 'The current practice on top-ups, which prohibits people from privately purchasing drugs not available on the health service while continuing a course of NHS care, is untenable.'
Listen to the debate at www.kingsfund.org.uk
Labour proposes amendments to Healthcare Safety Investigations Branch bill Shadow health secretary attacks Matt Hancock’s promotion of GP at Hand Jonathan Ashworth raises prospect of legally enforced staffing ratios Labour have threatened to table amendments to the government’s Healthcare Safety
Dementia is the health crisis of our time and the government needs to pull up its socks with an increase in dementia research, notes Hilary Evans
Andy Cowper discusses the possible consequences of a likely “no deal” Brexit for the NHS
We are aware that some of our users are experiencing problems accessing hsj.co.uk.
To protect your security as hsj.co.uk upgrades to a new platform, your existing password will no longer work.
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay
No comments yet